Breaking News Instant updates and real-time market news.

MRCC

Monroe Capital

$9.16 /

+0.09 (+0.99%)

12:42
08/08/22
08/08
12:42
08/08/22
12:42

Monroe Capital downgraded at Oppenheimer on wider credit spreads, rising rates

Oppenheimer analyst Mitchel Penn downgraded Monroe Capital to Perform from Outperform with a price target of $10, down from $11, after the company lost (34c) per share in Q2, equating to an ROE of negative 12.3%, as credit spreads widened and rates rose. Penn estimates Monroe Capital can earn a 9.0% ROE and with a higher estimated cost of equity capital of 9.75% to account for the macro headwinds, he calculates a fair value of $10, prompting his downgrade given that the stock is currently trading around $9.15.

OTHER BREAKING NEWS FROM THE FLY

Upgrade
Snam upgraded to Neutral from Sell at Citi » 04:47
09/27/22
09/27
04:47
09/27/22
04:47
SNMRF

Snam

$4.73 /

+ (+0.00%)

Citi analyst Antonella…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNMRF Snam
$4.73 /

+ (+0.00%)

09/23/22 Barclays
Snam price target lowered to EUR 5.30 from EUR 5.40 at Barclays
09/15/22 Societe Generale
Snam upgraded to Buy from Hold at Societe Generale
09/14/22 Credit Suisse
Snam price target lowered to EUR 5 from EUR 5.10 at Credit Suisse
09/01/22 JPMorgan
Snam price target raised to EUR 5.20 from EUR 5.15 at JPMorgan
Initiation
Inchcape initiated with a Buy at Berenberg » 04:45
09/27/22
09/27
04:45
09/27/22
04:45
IHCPF

Inchcape

$10.00 /

+ (+0.00%)

Berenberg analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
ViewRay seeing order book momentum into year-end, says Piper Sandler » 04:42
09/27/22
09/27
04:42
09/27/22
04:42
VRAY

ViewRay

$3.53 /

-0.16 (-4.34%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

09/07/22 Piper Sandler
ViewRay approval 'another nice positive' for story, says Piper Sandler
08/02/22 Piper Sandler
ViewRay price target lowered to $6 from $7 at Piper Sandler
06/24/22 BTIG
ViewRay price target lowered to $8 from $9 at BTIG
05/06/22 Piper Sandler
ViewRay price target lowered to $7 from $9 at Piper Sandler
VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

  • 17
    Nov
VRAY ViewRay
$3.53 /

-0.16 (-4.34%)

Recommendations
Snap price target raised to $12 from $11 at Piper Sandler » 04:40
09/27/22
09/27
04:40
09/27/22
04:40
SNAP

Snap

$10.17 /

-0.15 (-1.45%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$10.17 /

-0.15 (-1.45%)

SNAP Snap
$10.17 /

-0.15 (-1.45%)

09/23/22 JPMorgan
Snap price target raised to $10 from $9 at JPMorgan
09/16/22 Morgan Stanley
Snap price target raised to $10 from $8 at Morgan Stanley
09/13/22 Evercore ISI
Snap price target raised to $17 from $14 at Evercore ISI
09/08/22 UBS
UBS 'encouraged' by Snap's bullish targets for FY23
SNAP Snap
$10.17 /

-0.15 (-1.45%)

SNAP Snap
$10.17 /

-0.15 (-1.45%)

SNAP Snap
$10.17 /

-0.15 (-1.45%)

SNAP Snap
$10.17 /

-0.15 (-1.45%)

Downgrade
Keurig Dr Pepper downgraded to Neutral from Buy at Goldman Sachs » 04:38
09/27/22
09/27
04:38
09/27/22
04:38
KDP

Keurig Dr Pepper

$37.28 /

+0.2 (+0.54%)

Goldman Sachs analyst…

Goldman Sachs analyst Bonnie Herzog downgraded Keurig Dr Pepper to Neutral from Buy with a price target of $37, down from $39. The company continues to execute well in a challenging environment but the stock's risk/reward is more balanced at current levels, Herzog tells investors in a research note. The analyst expects brewer household penetration starts to normalize, pod attach rates to moderate and for Keurig's packaged beverage business growth and market share gains to begin to slow in this environment. Furthermore, she sees increased risk to the company's margins as commodity inflation, especially related to coffee, remains elevated for Keurig versus its peers.

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$37.28 /

+0.2 (+0.54%)

KDP Keurig Dr Pepper
$37.28 /

+0.2 (+0.54%)

08/19/22 Jefferies
Jefferies concerned about potential Keurig acquisition of Vital
08/19/22 Bernstein
Keurig Dr Pepper may get Vital 'on the cheap,' says Bernstein
07/20/22 JPMorgan
Keurig Dr Pepper price target lowered to $42 from $44 at JPMorgan
06/21/22 UBS
Keurig Dr Pepper downgraded to Neutral from Buy at UBS
KDP Keurig Dr Pepper
$37.28 /

+0.2 (+0.54%)

KDP Keurig Dr Pepper
$37.28 /

+0.2 (+0.54%)

KDP Keurig Dr Pepper
$37.28 /

+0.2 (+0.54%)

KDP Keurig Dr Pepper
$37.28 /

+0.2 (+0.54%)

General news
European stock markets are broadly higher » 04:20
09/27/22
09/27
04:20
09/27/22
04:20
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Market Update: » 02:45
09/27/22
09/27
02:45
09/27/22
02:45
$ECON

Economic Data

/

+

Market Update: Stock…

Market Update: Stock markets started to stabilize overnight and Nikkei and ASX managed gains of 0.5% and -0.4% respectively. The CSI 300 is currently up 0.9%, while the Hang Seng is still down -0.5%. European and U.S. futures are higher though, with the Nasdaq outperforming and up 0.9%, as markets continue to digest last week's round of central bank announcement while fine tuning growth outlooks. The U.S. 10-year rate is down -7.9 bp at 3.85% and it seems bonds are also starting to find a footing, even if rates still moved up in Australia and New Zealand. The BoE was forced to issue a statement yesterday saying that it "will not hesitate to change interest rates as necessary", while stopping short of actually hiking rates immediate, as some had expected. The pound initially dropped on the comments, but cable stopped short of the all-time low of 1.35 seen early on Monday and has since backed up to 1.0806. Indeed, Sterling is higher across the board as markets prepare for 75-100 bp at the next official meeting and the Chancellor promised a plan to address the mounting debt level. EUR-USD also lifted among a general correction in the dollar. The DXY index remains at very high levels, but at 113.377 is below this week's highs clearly over 114. The front end WTI contract has stabilized and is at USD 77.91 per barrel.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Accenture collaborates with Toshiba to drive emission reductions » 21:06
09/26/22
09/26
21:06
09/26/22
21:06
ACN

Accenture

$257.59 /

-2.63 (-1.01%)

, TOSBF

Toshiba, also use TOSYY

$35.35 /

+ (+0.00%)

, TOSYY

Toshiba

$17.97 /

+0.11 (+0.62%)

The company states:…

The company states: "Accenture (ACN) is collaborating with Toshiba (TOSBF) to provide consulting services to support green transformation efforts of the companies' clients. The collaboration will target industries with high greenhouse gas emissions and other organizations with urgent needs to improve energy efficiency. Accenture will work with Toshiba to design and develop new sustainability services to drive emission reductions, in addition to strategies and solutions for carbon neutrality. Accenture will leverage its experience developing circular-economy business models and implementing sustainable supply chain processes, such as green procurement, as well as using cloud and other technology solutions from its partner ecosystem."

ShowHide Related Items >><<
TOSYY Toshiba
$17.97 /

+0.11 (+0.62%)

TOSBF Toshiba, also use TOSYY
$35.35 /

+ (+0.00%)

ACN Accenture
$257.59 /

-2.63 (-1.01%)

ACN Accenture
$257.59 /

-2.63 (-1.01%)

09/26/22 Barclays
Accenture price target lowered to $340 from $370 at Barclays
09/23/22 RBC Capital
Accenture price target lowered to $335 from $357 at RBC Capital
09/23/22 Deutsche Bank
Accenture price target lowered to $320 from $364 at Deutsche Bank
09/23/22 Cowen
Accenture price target lowered to $295 from $325 at Cowen
TOSBF Toshiba, also use TOSYY
$35.35 /

+ (+0.00%)

TOSYY Toshiba
$17.97 /

+0.11 (+0.62%)

04/28/22 Jefferies
Toshiba downgraded to Hold from Buy at Jefferies
ACN Accenture
$257.59 /

-2.63 (-1.01%)

TOSYY Toshiba
$17.97 /

+0.11 (+0.62%)

TOSBF Toshiba, also use TOSYY
$35.35 /

+ (+0.00%)

TOSBF Toshiba, also use TOSYY
$35.35 /

+ (+0.00%)

ACN Accenture
$257.59 /

-2.63 (-1.01%)

ACN Accenture
$257.59 /

-2.63 (-1.01%)

Hot Stocks
Cathie Wood's ARK Investment bought 1.03M shares of Ginkgo Bioworks today  20:13
09/26/22
09/26
20:13
09/26/22
20:13
DNA

Ginkgo Bioworks

$2.81 /

+0.015 (+0.54%)

 
ShowHide Related Items >><<
DNA Ginkgo Bioworks
$2.81 /

+0.015 (+0.54%)

DNA Ginkgo Bioworks
$2.81 /

+0.015 (+0.54%)

08/16/22 BTIG
Ginkgo Bioworks price target raised to $6 from $5 at BTIG
08/16/22 Raymond James
Ginkgo Bioworks price target raised to $14.50 from $11.50 at Raymond James
07/26/22 William Blair
Zymergen buyout deal 'best case scenario,' says William Blair
07/26/22 JPMorgan
Zymergen upgraded to Neutral from Underweight at JPMorgan
DNA Ginkgo Bioworks
$2.81 /

+0.015 (+0.54%)

DNA Ginkgo Bioworks
$2.81 /

+0.015 (+0.54%)

DNA Ginkgo Bioworks
$2.81 /

+0.015 (+0.54%)

Hot Stocks
Cathie Wood's ARK Investment bought 201K shares of CareDx today  20:11
09/26/22
09/26
20:11
09/26/22
20:11
CDNA

CareDx

$16.31 /

+0.175 (+1.08%)

 
ShowHide Related Items >><<
CDNA CareDx
$16.31 /

+0.175 (+1.08%)

CDNA CareDx
$16.31 /

+0.175 (+1.08%)

04/25/22 Stephens
CareDx initiated with an Overweight at Stephens
02/28/22 BTIG
CareDx price target lowered to $65 from $100 at BTIG
02/25/22 Craig-Hallum
CareDx price target lowered to $87 from $106 at Craig-Hallum
02/25/22 Raymond James
CareDx price target lowered to $52 from $90 at Raymond James
CDNA CareDx
$16.31 /

+0.175 (+1.08%)

Hot Stocks
Cathie Wood's ARK Investment bought 508K shares of Rocket Lab today  20:11
09/26/22
09/26
20:11
09/26/22
20:11
RKLB

Rocket Lab

$4.24 /

+0.115 (+2.79%)

 
ShowHide Related Items >><<
RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

Hot Stocks
Cathie Wood's ARK Investment bought 186K shares of Nvidia today  20:09
09/26/22
09/26
20:09
09/26/22
20:09
NVDA

Nvidia

$122.18 /

-3 (-2.40%)

 
ShowHide Related Items >><<
NVDA Nvidia
$122.18 /

-3 (-2.40%)

NVDA Nvidia
$122.18 /

-3 (-2.40%)

09/21/22 Morgan Stanley
Morgan Stanley says higher gaming GPU prices biggest takeaway from Nvidia event
09/21/22 BMO Capital
Nvidia price target lowered to $210 from $230 at BMO Capital
09/21/22 Susquehanna
Nvidia price target lowered to $190 from $200 at Susquehanna
09/21/22 Barclays
Nvidia offered little new in terms of announcements, says Barclays
NVDA Nvidia
$122.18 /

-3 (-2.40%)

NVDA Nvidia
$122.18 /

-3 (-2.40%)

NVDA Nvidia
$122.18 /

-3 (-2.40%)

NVDA Nvidia
$122.18 /

-3 (-2.40%)

Recommendations
QinetiQ price target lowered to 400 GBp from 411 GBp at Jefferies » 19:30
09/26/22
09/26
19:30
09/26/22
19:30
QNTQY

QinetiQ

$16.33 /

+ (+0.00%)

Jefferies analyst David…

Jefferies analyst David Farrell lowered the firm's price target on QinetiQ to 400 GBp from 411 GBp and keeps a Buy rating on the shares. While the company's proposed acquisition of Avantus strategically looks good and helps fill in a number of capabilities within the U.S., the deal's transaction multiple is driving his price target cut, the analyst tells investors in a research note.

ShowHide Related Items >><<
QNTQY QinetiQ
$16.33 /

+ (+0.00%)

09/22/22 Citi
QinetiQ upgraded to Buy from Neutral at Citi
08/09/22 JPMorgan
QinetiQ price target raised to 375 GBp from 355 GBp at JPMorgan
05/31/22 Citi
QinetiQ price target raised to 400 GBp from 382 GBp at Citi
05/20/22 Morgan Stanley
QinetiQ price target raised to 361 GBp from 331 GBp at Morgan Stanley
QNTQY QinetiQ
$16.33 /

+ (+0.00%)

Hot Stocks
Privia Health director sells $4.88M in common stock » 19:10
09/26/22
09/26
19:10
09/26/22
19:10
PRVA

Privia Health

$33.45 /

-0.99 (-2.87%)

In a regulatory filing,…

In a regulatory filing, Privia Health disclosed that is director Jeffrey Butler sold 140K shares of common stock on September 22nd in a total transaction size of $4.88M.

ShowHide Related Items >><<
PRVA Privia Health
$33.45 /

-0.99 (-2.87%)

PRVA Privia Health
$33.45 /

-0.99 (-2.87%)

09/07/22 Truist
Privia Health assumed with a Buy at Truist
09/01/22 Piper Sandler
Piper 'incrementally positive' on Privia, Signify after CMS data
08/25/22 Canaccord
Privia Health price target raised to $50 from $45 at Canaccord
08/12/22 Truist
Privia Health price target raised to $48 from $40 at Truist
PRVA Privia Health
$33.45 /

-0.99 (-2.87%)

  • 19
    Nov
PRVA Privia Health
$33.45 /

-0.99 (-2.87%)

On The Fly
Fly Intel: After-Hours Movers » 18:33
09/26/22
09/26
18:33
09/26/22
18:33
SANG

Sangoma Technologies

$5.76 /

-0.2 (-3.36%)

, NLS

Nautilus

$1.68 /

-0.04 (-2.33%)

, INGR

Ingredion

$79.02 /

-1.17 (-1.46%)

, XCUR

Exicure

$1.71 /

+0.18 (+11.76%)

Check out this evening's…

ShowHide Related Items >><<
XCUR Exicure
$1.71 /

+0.18 (+11.76%)

SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

NLS Nautilus
$1.68 /

-0.04 (-2.33%)

INGR Ingredion
$79.02 /

-1.17 (-1.46%)

SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

09/23/22 TD Securities
Sangoma Technologies price target lowered to C$18.50 from C$25 at TD Securities
09/22/22 William Blair
William Blair starts Sangoma with Outperform, sees over 30% upside
09/22/22 William Blair
Sangoma Technologies initiated with an Outperform at William Blair
05/26/22 Northland
Sangoma Technologies initiated with an Outperform at Northland
NLS Nautilus
$1.68 /

-0.04 (-2.33%)

05/24/22 Lake Street
Nautilus price target lowered to $5 from $14 at Lake Street
05/24/22 Truist
Nautilus price target lowered to $5 from $15 at Truist
05/24/22 Craig-Hallum
Craig-Hallum downgrades Nautilus to Hold, lowers price target to $2
05/24/22 Craig-Hallum
Nautilus downgraded to Hold from Buy at Craig-Hallum
INGR Ingredion
$79.02 /

-1.17 (-1.46%)

04/12/22 Credit Suisse
Ingredion downgraded to Neutral from Outperform at Credit Suisse
11/09/21
Fly Intel: Top five analyst initiations
11/09/21 Barclays
Ingredion initiated with an Overweight at Barclays
11/03/21
Fly Intel: Top five analyst upgrades
XCUR Exicure
$1.71 /

+0.18 (+11.76%)

08/16/22 Chardan
Exicure price target adjusted to $2 at Chardan to account for split
03/28/22 Chardan
Exicure price target lowered to 25c from 40c at Chardan
12/13/21 Chardan
Exicure downgraded to Neutral from Buy at Chardan
11/23/21 Chardan
Exicure price target lowered to $2.25 from $7 at Chardan
SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

NLS Nautilus
$1.68 /

-0.04 (-2.33%)

INGR Ingredion
$79.02 /

-1.17 (-1.46%)

SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

NLS Nautilus
$1.68 /

-0.04 (-2.33%)

NLS Nautilus
$1.68 /

-0.04 (-2.33%)

Hot Stocks
Malacca Straits Acquisition, Indiev enter business combination » 17:57
09/26/22
09/26
17:57
09/26/22
17:57
MLAC

Malacca Straits Acquisition

$10.25 /

+ (+0.00%)

Indiev, an electronic…

Indiev, an electronic vehicle company specializing in the design of next generation electric vehicles, and Malacca Straits Acquisition announced they have entered into a definitive merger agreement for a business combination that will result in Indiev becoming a wholly-owned subsidiary of Malacca. Indiev was founded in 2017. Under the terms of the merger agreement, Indiev will merge with a wholly-owned subsidiary of Malacca and the holders of the outstanding Indiev shares will receive shares in Malacca valued at $600M. In addition, the holders of Indiev shares will be eligible to earn up to an additional 20,000,000 shares on the achievement of performance milestones related to the price of the combined company's common stock for the period starting 150 days after the closing until December 31, 2024 and vehicle sales targets for the first and second full years following closing. Concurrently with the signing of the merger agreement, Hai Shi, founder and CEO of Indiev has signed a subscription agreement to purchase $15M of shares in Malacca at a price of $10.00 per share. Indiev's executive officers, including Shi, will lead the combined company. Prior to closing Indiev is expected to appoint a board of directors of five individuals, which will meet all corporate governance requirements for continued listing on the Nasdaq Capital Market, including a majority of independent directors, and any required California state diversity requirements. The boards of directors of both Indiev and Malacca have unanimously approved the proposed merger, which is subject to customary closing conditions, including receipt of all regulatory approvals, approval of the proposed merger by Indiev and Malacca's shareholders, and approval for listing of the combined company's shares on the Nasdaq Capital Market.The closing under the merger agreement and the PIPE transaction is anticipated to occur in the first quarter of 2023, with Malacca to domesticate from the Cayman Islands to a Delaware corporation prior to the closing. Malacca will be rebranded and operate as Indi Electric Vehicles Inc. and is expected to list on Nasdaq under the ticker symbol.

Hot Stocks
Lilly USA sued by EEOC over age discrimination » 17:30
09/26/22
09/26
17:30
09/26/22
17:30
LLY

Eli Lilly

$307.77 /

-3.76 (-1.21%)

Lilly USA violated…

Lilly USA violated federal law by intentionally failing to hire older workers based on their age for pharmaceutical sales representative positions from April 2017 to 2021, the U.S. Equal Employment Opportunity Commission charged in a lawsuit filed Monday. According to the EEOC's suit, in 2017, Lilly's senior vice president for human resources and diversity recognized at a Leadership Town Hall that Lilly's workforce was composed of older workers. The senior vice president then announced goals for "Early Career" hiring to add more millennials to Lilly's workforce. Thereafter, Lilly changed its hiring preferences and intentionally under-hired older candidates for sales representative positions in favor of younger candidates based on their age. Such alleged conduct violates the Age Discrimination in Employment Act which prohibits discrimination against applicants age 40 and over. The EEOC filed suit in the U.S. District Court for the Southern District of Indiana, Indianapolis Division after first attempting to reach a pre-litigation settlement through its conciliation process. The agency seeks back pay and liquidated damages for applicants subjected to unlawful age discrimination. The suit also seeks injunctive relief to prevent and correct age discrimination and training of Lilly's managers and supervisors about federal equal employment opportunity laws.

ShowHide Related Items >><<
LLY Eli Lilly
$307.77 /

-3.76 (-1.21%)

LLY Eli Lilly
$307.77 /

-3.76 (-1.21%)

09/22/22 UBS
UBS upgrades Eli Lilly to Buy, says most attractive in big pharma
09/14/22 Piper Sandler
Piper 'surprised' by negative Altimmune reaction after pemvidutide's 'big win'
09/13/22 Truist
Concert Pharmaceuticals price target raised to $25 from $22 at Truist
09/06/22 Morgan Stanley
Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
LLY Eli Lilly
$307.77 /

-3.76 (-1.21%)

LLY Eli Lilly
$307.77 /

-3.76 (-1.21%)

LLY Eli Lilly
$307.77 /

-3.76 (-1.21%)

LLY Eli Lilly
$307.77 /

-3.76 (-1.21%)

Earnings
Sangoma Technologies sees FY23 revenue $275M-$285M vs. $224.4M in FY22 » 17:24
09/26/22
09/26
17:24
09/26/22
17:24
SANG

Sangoma Technologies

$5.76 /

-0.2 (-3.36%)

Sees FY23 EBITDA in…

Sees FY23 EBITDA in $48M-$52M range vs. $42.1M last year.

ShowHide Related Items >><<
SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

09/23/22 TD Securities
Sangoma Technologies price target lowered to C$18.50 from C$25 at TD Securities
09/22/22 William Blair
William Blair starts Sangoma with Outperform, sees over 30% upside
09/22/22 William Blair
Sangoma Technologies initiated with an Outperform at William Blair
05/26/22 Northland
Sangoma Technologies initiated with an Outperform at Northland
SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

Earnings
Sangoma Technologies reports Q4 EPS ($2.99) vs. (4c) last year » 17:23
09/26/22
09/26
17:23
09/26/22
17:23
SANG

Sangoma Technologies

$5.76 /

-0.2 (-3.36%)

Reports Q4 revenue $62.5M…

Reports Q4 revenue $62.5M vs. $50.1M last year. "Our fourth quarter finished off another very strong year of results for Sangoma," said Bill Wignall, CEO. "I am pleased with our performance this year, especially given the ongoing economic headwinds and the challenging global environment. We continued to execute on our long-term SaaS focus as we've successfully transitioned to recurring revenue streams, with Sangoma now at over 70% Services revenue, up from 62% last year. We also successfully integrated the Star2Star business, and completed our most recent acquisition of NetFortris. We ended fiscal 2022 with record results on both the top line in revenue, and on the bottom line, with over $40 million in Adjusted EBITDA for the first time. This performance reinforces Sangoma's belief in our long-term strategy of growing organically and via prudent acquisitions, our commitment to doing so with profitability, and our ability to provide our customers with the widest set of cloud communications services in the industry. It's been another exciting year for Sangoma, so I'd like to express my gratitude to our customers, partners and investors, for their ongoing support. And, finally, I would also like to thank our great team of employees around the world for their contributions and hard work."

ShowHide Related Items >><<
SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

09/23/22 TD Securities
Sangoma Technologies price target lowered to C$18.50 from C$25 at TD Securities
09/22/22 William Blair
William Blair starts Sangoma with Outperform, sees over 30% upside
09/22/22 William Blair
Sangoma Technologies initiated with an Outperform at William Blair
05/26/22 Northland
Sangoma Technologies initiated with an Outperform at Northland
SANG Sangoma Technologies
$5.76 /

-0.2 (-3.36%)

Hot Stocks
Raytheon Technologies awarded $769.87M Navy contract modification » 17:19
09/26/22
09/26
17:19
09/26/22
17:19
RTX

Raytheon Technologies

$81.04 /

-0.99 (-1.21%)

Raytheon Technologies was…

Raytheon Technologies was awarded a $769.87M firm-fixed-price, cost-plus-fixed-fee modification to a previously awarded, indefinite-delivery/indefinite-quantity contract. This modification increases the contract ceiling to procure propulsion system spare parts, modules, support equipment/packaging handling shipping and transportation material, and depot lay-in material in support of the F-135 propulsion system requirements for the Air Force, Marine Corps, Navy, Foreign Military Sales customers and non-Department of Defense participants. Work is expected to be completed in December 2025. No funds will be obligated at the time of award; funds will be obligated on individual orders as they are issued. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$81.04 /

-0.99 (-1.21%)

RTX Raytheon Technologies
$81.04 /

-0.99 (-1.21%)

07/27/22 Wells Fargo
Raytheon Technologies price target lowered to $98 from $106 at Wells Fargo
07/27/22 RBC Capital
Raytheon Technologies price target lowered to $115 from $125 at RBC Capital
04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
RTX Raytheon Technologies
$81.04 /

-0.99 (-1.21%)

RTX Raytheon Technologies
$81.04 /

-0.99 (-1.21%)

RTX Raytheon Technologies
$81.04 /

-0.99 (-1.21%)

RTX Raytheon Technologies
$81.04 /

-0.99 (-1.21%)

Hot Stocks
L3Harris Technologies awarded $886.53M Army contract » 17:16
09/26/22
09/26
17:16
09/26/22
17:16
LHX

L3Harris Technologies

$215.70 /

-4.675 (-2.12%)

L3 Technologies was…

L3 Technologies was awarded an $886.53M cost-plus-fixed-fee contract for sustainment of the Common Data Link satellite communications program. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of September 22, 2032. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
LHX L3Harris Technologies
$215.70 /

-4.675 (-2.12%)

LHX L3Harris Technologies
$215.70 /

-4.675 (-2.12%)

08/29/22 RBC Capital
L3Harris Technologies initiated with an Outperform at RBC Capital
07/07/22 Canaccord
Mynaric price target lowered to $27 from $30 at Canaccord
05/02/22 Jefferies
L3Harris Technologies price target lowered to $300 from $320 at Jefferies
05/02/22 Susquehanna
L3Harris Technologies price target lowered to $298 from $302 at Susquehanna
LHX L3Harris Technologies
$215.70 /

-4.675 (-2.12%)

LHX L3Harris Technologies
$215.70 /

-4.675 (-2.12%)

LHX L3Harris Technologies
$215.70 /

-4.675 (-2.12%)

Syndicate
IMAC Holdings files to sell 10.3M shares of common stock for holders  17:02
09/26/22
09/26
17:02
09/26/22
17:02
BACK

IMAC Holdings

/

+

 
ShowHide Related Items >><<
BACK IMAC Holdings
/

+

BACK IMAC Holdings
/

+

Hot Stocks
Methanex invests in tech to reduce emissions at New Zealand site » 17:01
09/26/22
09/26
17:01
09/26/22
17:01
MEOH

Methanex

$29.39 /

+0.43 (+1.48%)

Methanex Corporation…

Methanex Corporation announced it has made a significant investment to reduce carbon emissions at its Motunui facility in New Zealand. This multi-million-dollar investment will involve improving the technology in the facility's distillation columns over the next 12 months. The efficiency improvements provide an economic payback within two years. Once completed, this project has the potential to reduce the site's carbon emissions by over 50,000 tonnes per annum, the equivalent of taking 20,000 cars off the road. "We're excited to announce this new investment in our Motunui facility as a demonstration of our commitment to emissions reduction in New Zealand and globally," said Stuart McCall, Managing Director, Methanex New Zealand. "With this new technology, we will no longer need to distill crude methanol at our Waitara Valley plant, thereby reducing our energy consumption and overall emissions."

ShowHide Related Items >><<
MEOH Methanex
$29.39 /

+0.43 (+1.48%)

MEOH Methanex
$29.39 /

+0.43 (+1.48%)

09/26/22 Scotiabank
Methanex upgraded at Scotiabank after 'unwarranted' selloff
09/26/22 Scotiabank
Methanex upgraded to Outperform from Sector Perform at Scotiabank
08/02/22 Barclays
Methanex price target lowered to $52 from $60 at Barclays
07/29/22 Piper Sandler
Methanex price target lowered to $40 from $48 at Piper Sandler
MEOH Methanex
$29.39 /

+0.43 (+1.48%)

MEOH Methanex
$29.39 /

+0.43 (+1.48%)

Periodicals
Musk, Agrawal deposition delay not for settlement talks, WSJ says » 16:55
09/26/22
09/26
16:55
09/26/22
16:55
TSLA

Tesla

$275.83 /

+0.58 (+0.21%)

, TWTR

Twitter

$41.64 /

-0.01 (-0.02%)

Tesla (TSLA) CEO Elon…

Tesla (TSLA) CEO Elon Musk's deposition for his attempt to terminate the merger agreement with Twitter is not happening on Monday and has been pushed back, the Wall Street Journal's Erin Mulvaney and Alexa Corse report, citing people familiar with the situation. Twitter (TWTR) CEO Parag Agrawal's deposition scheduled for Monday was canceled for personal reasons, the authors note. The deposition schedule changes are not due to settlement talks between Musk and Twitter, the authors say. Reference Link

ShowHide Related Items >><<
TWTR Twitter
$41.64 /

-0.01 (-0.02%)

TSLA Tesla
$275.83 /

+0.58 (+0.21%)

TSLA Tesla
$275.83 /

+0.58 (+0.21%)

09/20/22 Morgan Stanley
Tesla passing through 'peak China' dependency stage, says Morgan Stanley
09/16/22 Deutsche Bank
Tesla price target raised to $400 from $375 at Deutsche Bank
09/15/22 Wedbush
Biden focused EV initiatives step in right direction, says Wedbush
09/14/22 Needham
Tesla assumed at Hold as Needham doesn't see catalyst for underperformance
TWTR Twitter
$41.64 /

-0.01 (-0.02%)

08/24/22 Gordon Haskett
Twitter whistleblower has no 'smoking gun,' says Gordon Haskett
08/24/22 Rosenblatt
Rosenblatt downgrades Twitter on risk of Musk using whistleblower suit
08/24/22 Rosenblatt
Twitter downgraded to Neutral from Buy at Rosenblatt
08/10/22 Gordon Haskett
Tesla sale shows Musk knows must come up with Twitter money, says Gordon Haskett
TWTR Twitter
$41.64 /

-0.01 (-0.02%)

TSLA Tesla
$275.83 /

+0.58 (+0.21%)

TSLA Tesla
$275.83 /

+0.58 (+0.21%)

TWTR Twitter
$41.64 /

-0.01 (-0.02%)

TSLA Tesla
$275.83 /

+0.58 (+0.21%)

TWTR Twitter
$41.64 /

-0.01 (-0.02%)

TSLA Tesla
$275.83 /

+0.58 (+0.21%)

Hot Stocks
Atlis Motor Vehicles approved to trade on Nasdaq » 16:53
09/26/22
09/26
16:53
09/26/22
16:53
AMV

Atlis Motor Vehicles

$7.85 /

+ (+0.00%)

Atlis Motor Vehicles…

Atlis Motor Vehicles announced that Nasdaq has approved its application to list on Nasdaq Exchange. The company anticipates initiation of trading on the Nasdaq exchange on September 27. Atlis will be traded under the symbol (AMV).

ShowHide Related Items >><<
AMV Atlis Motor Vehicles
$7.85 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.